Drugs & Pharmaceuticals

With bomb cyclones, blizzard conditions and a polar vortex prompting school closures and other restrictions, it would seem an optimal time to detail cold-related illnesses and deaths for the purposes of prevention. But, been there, done that.

Orrin Hatch, a Republican Senator from Utah, has announced his retirement. When he leaves, the Senate will lose its most ardent supporter of alternative medicine.

Those in Hollywood are in a unique position to do tremendous good given their substantial platform. Unfortunately, with that megaphone comes immense responsibility.

This year brought about a number of public discussions surrounding not only less mainstream medical conditions, but also physically and emotionally challenging and ethically complex ones.

The world of contraception might soon have a new participant — if the upcoming trials are successful. And this one’s for men.

All I want for Christmas is for people just to tell it like it is in medical advertising in all its forms. Promise nothing more and nothing less than what they, their institution or product actually do or mean. Stop the selling.

Recently, I had the pleasure of filming a segment on the top medical, science and technology innovations of 2017 at Reuters TV in Times Square, New York with host of CCTV Bianca Chen.

Back in May, the FDA issued a blueprint of proposed changes for physicians who manage pain.

Don't let the title discourage you even though it's pretty bad: "Design of MC1R Selective γ-MSH Analogues with Canonical Amino Acids Leads to Potency and Pigmentation"

It was a scene right out of a Robert Ludlum novel.